Back close
Admissions

Dr. Binoj S. T.

Professor, Department of Gastrointestinal Surgery, School of Medicine, Kochi

Qualification: MBBS,MS,DNB
binojst10574@aims.amrita.edu

Bio Publications Qualification Achievements Memberships Roles
Bio

Dr. Binoj S. T. currently serves as Professor at the Department of Gastrointestinal Surgery, School of Medicine, Kochi.

Qualification
  • MBBS
  • MS (General Surgery)
  • DNB (Surgical Gastroenterology)
  • Fellowship in Minimal Access Surgery
Achievements
  • Won the best poster Award at International Liver Symposium in New Delhi. (2011) “Cost of Immunosupression using Generic Products After Liver Transplantation.”
  • Won the Best Poster award at the Kerala chapter of the Association of Surgeon of India State Conference, Kochi (2010) “Liver Transplantation – Moving Up the Learning curve”
Memberships
  • Indian Medical Association.
  • Indian Association of Surgical Gastroenterologists.
  • Association of Surgeons of India.
  • Association of Minimal Access Surgeons of India.
Roles
  • Co-Investigator, A Multinational, Multiceter, Randomized, Double Blinded Study comparing the Efficacy and Safety of Trial drug (AVE5026) with enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Abdominal Surgery. (2009-2010)
  • Co-Investigator, A Randomized, double blind, multicentric, placebo controlled, single dose, phase – II study assessing the safety and efficacy of intramuscular ex vivo cultured adult allogenic mesenchymal stem cells in patients with critical limb ischemia (CLI). (2009-2011)
  • Co-Investigator, Neoadjuvant ChemoRT followed by surgery versus Neoadjuvant Chemo RT + Trial Drug Followed by surgery in Ca Esophagus. Prospective Multi centre Randomised Control Trial. (2008-2010)
  • Co-Investigator, A Prospective, Multicenter, Double-blind, Randomized, Comparative Study to estimate the safety, tolerability and efficacy of Trial drug (NXL104)/Ceftazidime plus Metronidazole vs. Meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults. (2009-2010)
  • Co-Investigator, A Phase III, Double Blind, Randomized Study to Evaluate the Safety and Efficacy of Isavuconazole Versus Caspofungin Followed by Voriconazole Regimen in the Treatment of Candidemia and Other Invasive Candida Infections. (2009-2010)
Admissions Apply Now